MYRIAD GENETICS INC
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Accelerated filer
State of Incorporation DE
Business Address 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Mailing Address 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Phone 801-584-3600
Fiscal Year End 1231
EIN 870494517
Financial Overview
FY2025
$338.60M
Total Liabilities
$885.80M
Stockholders' Equity
$-1.41
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
Insider Trading
STRONG BUY 2 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
IMMUCELL CORP /DE/
ICCC In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
ACHIEVE LIFE SCIENCES, INC.
ACHV In Vitro & In Vivo Diagnostic Substances
Q/C TECHNOLOGIES, INC.
QCLS In Vitro & In Vivo Diagnostic Substances
Cardio Diagnostics Holdings, Inc.
CDIO In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.